Publication

Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab

Journal Paper/Review - Aug 9, 2019

Units
Keywords
PubMed
Doi
Link
Contact

Citation
Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet I, Kremer Hovinga J. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Am J Hematol 2019; 94:E259-E261.
Project
Type
Journal Paper/Review (English)
Journal
Am J Hematol 2019; 94
Publication Date
Aug 9, 2019
Issn Print
Issn Electronic
1096-8652
Pages
E259-E261
Publisher
Brief description/objective